(Q44124651)

8 January 2018

title

Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer (English)

1 reference

8 January 2018

adaptive radiation therapy

main subject

0 references

0 references

0 references

1 reference

Daniel E Spratt

1

0 references

Michael J Zelefsky

object named as

Michael J Zelefsky

6

0 references

author name string

Xin Pei

2

1 reference

8 January 2018

Josh Yamada

3

1 reference

8 January 2018

Marisa A Kollmeier

4

1 reference

8 January 2018

Brett Cox

5

1 reference

8 January 2018

language of work or name

English

0 references

publication date

12 July 2012

1 reference

8 January 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

8 January 2018

volume

85

1 reference

8 January 2018

issue

3

1 reference

8 January 2018

page(s)

686-692

1 reference

8 January 2018

Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

What dose of external-beam radiation is high enough for prostate cancer?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705018

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer

15 August 2018

1 reference

12 December 2020

HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

1 reference

12 December 2020

Biopsy-proved tumor following definitive irradiation for resectable carcinoma of the prostate

1 reference

12 December 2020

Dose response in prostate cancer with 8-12 years' follow-up

1 reference

12 December 2020

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity

1 reference

12 December 2020

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

12 December 2020

A dose-response study for I-125 prostate implants

1 reference

12 December 2020

Ultra-High Dose (86.4 Gy) IMRT for Localized Prostate Cancer: Toxicity and Biochemical Outcomes

1 reference

12 December 2020

Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer

1 reference

12 December 2020

10.1016/J.IJROBP.2012.05.023

Identifiers

DOI

1 reference

8 January 2018

PMC publication ID

5705018

1 reference

8 January 2018

PubMed publication ID

22795805

1 reference

8 January 2018